
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
[ Mon, Nov 21st 2022 ]: WOPRAI
John Ransom Downgraded (ALHC) to Hold on, Nov 21st, 2022


🞛 This publication is a summary or evaluation of another publication
John Ransom of Raymond James, Downgraded "Alignment Healthcare, Inc." (ALHC) to Hold on, Nov 21st, 2022.
John has made no other calls on ALHC in the last 4 months.
There are 6 other peers that have a rating on ALHC. Out of the 6 peers that are also analyzing ALHC, 1 agrees with John's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Kevin Caliendo of "UBS" Maintained at Hold with Increased Target to $17 on, Monday, August 8th, 2022
These are the ratings of the 5 analyists that currently disagree with John
- Gary Taylor of "Cowen & Co." Maintained at Buy with Increased Target to $17 on, Monday, August 22nd, 2022
- Ricky Goldwasser of "Morgan Stanley" Maintained at Buy with Increased Target to $19 on, Wednesday, August 10th, 2022
- Sarah James of "Barclays" Maintained at Buy with Increased Target to $21 on, Monday, August 8th, 2022
- Nathan Rich of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $21 on, Monday, August 8th, 2022
- Jeff Garro of "Piper Sandler" Maintained at Buy with Increased Target to $20 on, Friday, August 5th, 2022